Metformin in the management of fibrocystic breast disease: a placebo-controlled randomized clinical trial

BACKGROUND AND PURPOSE: Fibrocystic disease (FCD) of the breast as a very common health problem in women has estrogen-dependent and proliferative features. No effective management strategy has been validated for this disorder, so far. The anti-hyperglycemic agent metformin has both anti-proliferativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Alipour, Sadaf, Rastad, Hadith, Saberi, Azin, Faiz, Firoozeh, Maleki-Hajiagha, Arezoo, Abedi, Mahboubeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557102/
https://www.ncbi.nlm.nih.gov/pubmed/34719004
http://dx.doi.org/10.1007/s40199-021-00424-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557102/
https://www.ncbi.nlm.nih.gov/pubmed/34719004
http://dx.doi.org/10.1007/s40199-021-00424-6

Ejemplares similares